Skip to the chapter Tirzepatide Finding someone to prescribe tirzepatide Chapter index - First check Find a route - Fact check Know the medicine - Question list Prepare for care - Cost checklist Untangle payment Cost checklist · Payment # Ask for the whole cost. Then compare. Ask for a written breakdown of the medicine, visits, tests and follow-up. Write beside each price whether you would pay it yourself or use insurance. A small note can untangle a big bill. ## What does the headline price cover? Medicine Which medicine, in an injection pen or a small bottle, and how much is included? Care Is the health check billed per visit or as an ongoing membership? Tests and follow-up Which checks and messages are included? What could be billed separately? Commitment Must I pay in advance, keep getting refills or agree to a longer contract? What would I pay after an introductory offer ends, and how do I cancel? ## A starting cash price is only a starting point As of September 26, 2026, the government price page listed tirzepatide (Zepbound) from $299 per month. That starting figure applied to the lowest strength, meaning the smallest amount of medicine per injection; it was not a price for every prescription. A drug maker’s published figure is its list price; a cash offer or an insurance copay means something different. The patient’s share of a bill covered by insurance is called a copay. Source: U.S. government prescription price directory ↗ Ask for the price for your exact prescription, both with insurance and if you pay yourself. Write down what is included and when the offer ends. For people using Medicare ## A temporary Medicare payment program Part D means Medicare prescription-drug coverage. As of September 2026, qualifying Part D members pay a $50 monthly copay under the temporary Medicare GLP-1 Bridge program. The September 2026 check gives a scheduled start of July 1, 2026 and an end of December 31, 2027. Source: Medicare’s Bridge program, Centers for Medicare & Medicaid Services ↗ For tirzepatide (Zepbound), Bridge covers only the KwikPen, an injection pen holding several doses, as of September 2026. Single-dose pens, used for one injection, and vials, small medicine bottles, are excluded from Bridge, as of September 2026. To apply, you need a prescription and program approval, and must be at least 18, as of September 2026. Your coverage, as of September 2026, must be either a separate drug plan under Part D or an eligible Medicare Advantage plan that includes medicines. As of September 2026, the health rules use body mass index (BMI), a figure calculated from height and weight. - One way to meet the weight rule is a BMI of 35 or more. - With a BMI of 30 or more, certain heart failure, hard-to-control high blood pressure or kidney disease can qualify. - With a BMI of 27 or more, qualifying problems include a previous heart attack, a previous stroke, prediabetes, or disease of the blood vessels in the arms or legs with symptoms. Prediabetes means sugar in the blood is higher than normal, but has not reached the level for diabetes. Ask whoever writes your prescription to compare your health records with the precise health rules. Ask your plan whether its type of coverage is included. Source: Medicare’s product and eligibility rules ↗ Ask the plan - Do I qualify for Bridge? - Is this medicine and its injection pen included? - What approval must the person writing my prescription request? ## Check what that payment counts toward As of September 2026, the $50 you pay for Bridge does not go toward the annual limit on your medicine spending through normal Part D coverage. So these payments do not bring you closer to that cap, even though the money comes out of your pocket. You cannot use a coupon to reduce a prescription’s $50 Bridge payment, as of September 2026. Source: Medicare’s consumer guide to weight-loss drug coverage ↗ The usual Part D insurance process is separate from Bridge’s temporary $50 program, as of September 2026. Medicare’s usual Part D rules may cover tirzepatide (Mounjaro) when it is prescribed for type 2 diabetes, as of September 2026. Zepbound may be covered, as of September 2026, for adults with obesity whose obstructive sleep apnea is moderate to severe. This means repeated breathing blockages during sleep; the severity and weight requirements matter. People with type 2 diabetes or this sleep condition must check usual Part D coverage rather than Bridge, as of September 2026. Possible coverage does not guarantee that your plan will pay; check its list of covered medicines and approval rules. Prior authorization means the plan must approve payment before the pharmacy fills the prescription. Source: Medicare’s guidance on usual prescription coverage ↗ ## Payment questions for any care route - Is this price for paying myself or using insurance? - Will the plan cover this medicine for the reason it is being prescribed? - What happens to the cost if the plan declines payment? - Can I see the refill and cancellation terms in writing? - What amount would I pay for ongoing care as well as the medicine? Carry this forward ## Keep the medicine, how you will pay and the full bill together in the same note. Return to the questions for your visit → This guide helps you find the next question on the way to tirzepatide care; it is no clinic and sells no medicine. Back to the first check Read this chapter as text Full text edition Room for questions. Time to think.